Pay workers who are required to undergo COVID-19 screenings: lawsuit
By
Kimberly Bonvissuto
Mar 26, 2021
A Wisconsin proposed collective and class action complaint alleging healthcare workers should be paid for undergoing mandatory COVID-19 screenings is “one to watch,” especially for healthcare employers...
A new day in the battle against COVID
By
Lois A. Bowers
Jan 20, 2021
We all can agree that we’d like to see an end to the illness and death caused by the coronavirus. We’d like families and residents to be able to hug one another again. We’d like to stop having to...
Adverse effects generally mild after BNT162b2 mRNA booster in over 60s
Apr 18, 2022
Thirty percent of those aged 60 years or older receiving a booster reported at least one adverse event; few sought medical attention.
Disparities in COVID-19 vaccination identified among healthcare employees
Jun 16, 2021
Vaccination was least likely among clinical nurses, support staff and workers at skilled nursing and rehabilitation facilities.
CDC estimates U.S. COVID-19 infections now close to 140 million
Mar 02, 2022
The new findings are from the CDC national antibody seroprevalence survey of antibodies to the coronavirus triggered by infection, not by vaccination.
Assisted living providers largely on their own during pandemic crisis: report
By
Kimberly Bonvissuto
May 11, 2021
Confusing, and sometimes conflicting, coronavirus pandemic information and guidance from Delaware’s public health officials often left assisted living community administrators on their own in the middle...
Reasons for hope as a new week begins
By
Lois A. Bowers
Sep 13, 2021
We start the week with reasons to hope despite the pandemic.
Pfizer-BioNTech COVID-19 vaccine receives full FDA approval
Aug 23, 2021
The vaccine will now be marketed as Comirnaty and is fully approved for the prevention of COVID-19 in individuals 16 years and older.
Thrombosis, thrombocytopenia syndrome up after Ad26.COV2.S
Jan 28, 2022
Rates of 3.83 per million vaccine doses for Ad26.COV2.S (Johnson & Johnson) have been reported, versus 0.00855 per million for mRNA-based vaccines such as Pfizer-BioNTech and Moderna.
ACC offers guidance on cardiovascular sequelae of COVID-19
Mar 18, 2022
The guidelines address myocarditis and other types of myocardial involvement, postacute sequelae of SARS-CoV-2 and return to exercise.